What considerations did the committee take into account when assessing potential harms and benefits of chronic heart failure interventions?
The committee took into account the net clinical benefit over harm (clinical effectiveness) when assessing potential harms and benefits of chronic heart failure interventions. They considered the critical outcomes, clinical benefits and harms, and importance placed on the outcomes (the committee's values and preferences), and the confidence the committee had in the evidence (evidence quality). They also assessed whether the net clinical benefit justified any differences in costs between the alternative interventions, and considered current practices, recommendations made in other relevant guidelines, patient preferences, and equality issues.